The 2011 Leading Life Science Intermediates Companies Collaborations

October 2010 | 70 pages | ID: L90BDBAF367EN
Venture Planning Group

Abstracts

Global PDF: US$ 3,900.00

For each company, the report presents:

• Major joint venture, distribution, OEM and licensing partners, both industrial and academic.
• Terms of collaborative agreements and specific products involved.

The companies analyzed in the report: BASF, Bayer/Lanxess, Cambrex, Clariant, DowPharma, DSM, Evonik, Lonza, Novasep, and Rhodia.

Contains 70 pages